Whether or when atypical cases of acral CD8+ lymphoma require staging and more active management is unclear, but we suggest that caution is warranted in these atypical examples and certainly staging investigations are justified, with complete tumor removal advisable. The gene discussed is CD8A; the disease is lymphoma.